An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX ® in Patients With Hemophilia B
Condition: Hemophilia B Interventions: Genetic: HEMGENIX; Biological: Factor IX (FIX) Sponsor: CSL Behring Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials